- Dry goods|What you want to know about "single cell sequencing technology and applications" are here! 2019-01-19
- Happy news! Accurate and standard counterparts, Ripple's full score through the national tumor somatic mutation high-throughput 2018-11-29
- Case Study|Rip detection found a rare mutation in EGFR to expand the EGFR-TKI mutation spectrum 2019-01-19
- Accurate medical treatment, testing first--Rip gene was invited to appear at the 2018 annual meeting of the Hebei Provincial Ant 2018-12-04
- Accurate testing guides accurate diagnosis and treatment | Changan Hospital, Ripgen gene signed agreement, reached a deep strate 2019-01-19
Hangzhou Repugene Technology Co., Ltd. is a world class, industry leading, multi platform company lead by a diverse team of overseas returnees.
Our platform includes independent research and development that emcompasses precise areas such as clinical oncology diagnosis, efficient identification and
drug resistance analysis of pathogenic microorganisms, comprehensive genome screening, general health care data management. Repugene will continue to
apply leading healthcare technology to clinical research and the pursuit of superior efficacious therapies and diagnostic methods, providing healthy and
patient populations with precise medical services.
Happy news! Accurate and standard counterparts, Ripple's full score through the national tumor somatic mutation high-throughput
Case Study|Rip detection found a rare mutation in EGFR to expand the EGFR-TKI mutation spectrum
Let precision health care enter the public